Evaluate the Safety and Feasibility of Same-Day Bilateral Epithelium-On Corneal Cross-Linking for Keratoconus

Part of paid clinical trials in Westerville, Ohio.

Sponsor
Glaukos Corporation
Study ID
NCT07629557
Phase
PHASE4
Status
Recruiting
Apply to this trial

Conditions

  • Keratoconus

Eligibility Criteria

Sex
ALL
Age
13 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Riboflavin Ophthalmic Solutions — DRUG
    Riboflavin Ophthalmic Solutions
  • UV-A Irradiation System — DEVICE
    O2n UV-A Irradiation System

Study Details

Clinical trial to evaluate the safety and feasibility of corneal cross-linking in both eyes on the same day in subjects with keratoconus.

Key Dates

Start date
May 11, 2026
Status verified
Jun 2026
Primary completion
Sep 30, 2027
Completion
Sep 30, 2027

Study Design

Enrollment
15 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Epioxa™ HD/Epioxa™ and UV-A Irradiation
    Epioxa™ HD/Epioxa™ and UV-A Irradiation using the O2n™ System and Supplemental Oxygen using the Boost Goggles®

Primary Outcome Measure

Successful completion of bilateral epithelium-on corneal collagen cross-linking. [ Time Frame: Approximately 2.5 Months ]

Central Contacts

Locations (1)

FacilityCityStateZIP
Glaukos Investigative SiteWestervilleOhio43082

Find similar trials in Westerville, OH

By research site
Glaukos Investigative Site· Westerville, OH

Related Studies